Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Vertex Pharmaceuticals and Moderna Therapeutics are joining to research Moderna’s mRNA technology for the treatment of cystic fibrosis. Vertex, which markets two CF medicines, will pay Moderna $20 million in cash and invest an equal amount in the biotech firm. Vertex could pay future milestones of up to $275 million. Moderna struck a $200 million mRNA vaccine deal with Merck & Co. late last month. It raised $450 million from investors last year.
This article has been sent to the following recipient: